Trial intelligence / Profile preview

Esomeprazole vs Lansoprazole Maintenance in Healed Erosive Esophagitis

NCT00644735Phase 4Completed

Sponsor
AstraZeneca
Start
Dec 2002
Primary completion
Jan 2004
Modality
Small Molecules
01

Overview

A Phase 4 trial of esomeprazole in erosive esophagitis (EE), sponsored by AstraZeneca. Started Dec 2002; status: completed.

02

Drugs

esomeprazole
03

Conditions

erosive esophagitis (EE)

Beyond the preview

Go deeper on NCT00644735.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00644735.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call